|
Volumn 28, Issue S4, 2013, Pages 79-80
|
Treatment of non-alcoholic fatty liver disease
|
Author keywords
Clinical; Fatty liver; NAFLD; NASH; Treatment
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALANINE AMINOTRANSFERASE;
PIOGLITAZONE;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INFLAMMATION;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIFESTYLE MODIFICATION;
NONALCOHOLIC FATTY LIVER;
NONHUMAN;
PATHOPHYSIOLOGY;
PHYSICAL ACTIVITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK FACTOR;
WEIGHT REDUCTION;
CLINICAL;
FATTY LIVER;
NAFLD;
NASH;
TREATMENT;
ANIMALS;
FATTY LIVER;
HUMANS;
INFLAMMATION;
INSULIN RESISTANCE;
LIFE STYLE;
LIVER TRANSPLANTATION;
MOTOR ACTIVITY;
MULTICENTER STUDIES AS TOPIC;
NECROSIS;
PHLEBOTOMY;
RISK FACTORS;
THIAZOLIDINEDIONES;
|
EID: 84897596069
PISSN: 08159319
EISSN: 14401746
Source Type: Journal
DOI: 10.1111/jgh.12242 Document Type: Article |
Times cited : (7)
|
References (5)
|